Tenon Medical (TNON) Cash & Equivalents (2021 - 2026)

Tenon Medical has reported Cash & Equivalents for 6 years, with the latest figure at $1.7 million in Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 78.63% year-over-year to $1.7 million in Q2 2026; TTM through Jun 2026 was $1.7 million, a 78.63% decrease from a year earlier, with the FY2025 full-year figure at $3.8 million, down 42.52% from the prior year.
• Cash & Equivalents was $1.7 million for Q2 2026 at Tenon Medical, down from $4.6 million in the prior quarter.
• The five-year high for Cash & Equivalents was $10.3 million in Q1 2025, with the low at $1.7 million in Q2 2026.
• Average Cash & Equivalents over 5 years is $4.8 million, with a median of $4.1 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Cash & Equivalents jumped 298.68% in 2025, then sank 78.63% in 2026.
• Over 5 years, Cash & Equivalents stood at $2.1 million in 2022, then grew by 14.04% to $2.4 million in 2023, then surged by 169.15% to $6.5 million in 2024, then sank by 42.52% to $3.8 million in 2025, then plunged by 55.35% to $1.7 million in 2026.
• The last three Cash & Equivalents figures came in at $1.7 million (Q2 2026), $4.6 million (Q1 2026), and $3.8 million (Q4 2025), per Business Quant data.